216 related articles for article (PubMed ID: 25433523)
21. [Floating-Harbor syndrome: a case report and literature review].
Li RM; Lu YC; Li Z; Wang JY; Chang J; Lei SQ; Zeng Q; Sang YM
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Dec; 21(12):1208-1211. PubMed ID: 31874661
[TBL] [Abstract][Full Text] [Related]
22. Growth and Clinical Characteristics of Children with Floating-Harbor Syndrome: Analysis of Current Original Data and a Review of the Literature.
Homma TK; Freire BL; Honjo R; Dauber A; Funari MFA; Lerario AM; Albuquerque EVA; Vasques GA; Bertola DR; Kim CA; Malaquias AC; Jorge AAL
Horm Res Paediatr; 2019; 92(2):115-123. PubMed ID: 31715605
[TBL] [Abstract][Full Text] [Related]
23. Floating-Harbor syndrome with chorioretinal colobomas.
Alanis S; Blair MP; Kaufman LM; Bhat G; Shapiro MJ
Ophthalmic Genet; 2024 Apr; 45(2):207-209. PubMed ID: 37722826
[TBL] [Abstract][Full Text] [Related]
24. Single Amino Acid Change Underlies Distinct Roles of H2A.Z Subtypes in Human Syndrome.
Greenberg RS; Long HK; Swigut T; Wysocka J
Cell; 2019 Sep; 178(6):1421-1436.e24. PubMed ID: 31491386
[TBL] [Abstract][Full Text] [Related]
25. Floating-Harbor Syndrome: report on a case in a mother and daughter, further evidence of autosomal dominant inheritance.
Arpin S; Afenjar A; Dubern B; Toutain A; Cabrol S; Héron D
Clin Dysmorphol; 2012 Jan; 21(1):11-14. PubMed ID: 21955542
[TBL] [Abstract][Full Text] [Related]
26. Intracranial vascular pathology in two further patients with Floating-Harbor syndrome: Proposals for cerebrovascular disease risk management.
Menzies L; D'Arco F; Ganesan V; Hurst JA
Eur J Med Genet; 2020 Apr; 63(4):103785. PubMed ID: 31605816
[TBL] [Abstract][Full Text] [Related]
27. Clinical and genetic characteristics and effects of long-term growth hormone therapy in a girl with Floating-Harbor syndrome.
García RJ; Kant SG; Wit JM; Mericq V
J Pediatr Endocrinol Metab; 2012; 25(1-2):207-12. PubMed ID: 22570979
[TBL] [Abstract][Full Text] [Related]
28. The defining DNA methylation signature of Floating-Harbor Syndrome.
Hood RL; Schenkel LC; Nikkel SM; Ainsworth PJ; Pare G; Boycott KM; Bulman DE; Sadikovic B
Sci Rep; 2016 Dec; 6():38803. PubMed ID: 27934915
[TBL] [Abstract][Full Text] [Related]
29. Missense variant in SRCAP with distinct DNA methylation signature associated with non-FLHS SRCAP-related neurodevelopmental disorder.
White-Brown A; Choufani S; ; Weksberg R; Dyment D
Am J Med Genet A; 2023 Oct; 191(10):2640-2646. PubMed ID: 37340855
[TBL] [Abstract][Full Text] [Related]
30. Deletions in the 3' part of the NFIX gene including a recurrent Alu-mediated deletion of exon 6 and 7 account for previously unexplained cases of Marshall-Smith syndrome.
Schanze D; Neubauer D; Cormier-Daire V; Delrue MA; Dieux-Coeslier A; Hasegawa T; Holmberg EE; Koenig R; Krueger G; Schanze I; Seemanova E; Shaw AC; Vogt J; Volleth M; Reis A; Meinecke P; Hennekam RC; Zenker M
Hum Mutat; 2014 Sep; 35(9):1092-100. PubMed ID: 24924640
[TBL] [Abstract][Full Text] [Related]
31. The human SRCAP chromatin remodeling complex promotes DNA-end resection.
Dong S; Han J; Chen H; Liu T; Huen MSY; Yang Y; Guo C; Huang J
Curr Biol; 2014 Sep; 24(18):2097-2110. PubMed ID: 25176633
[TBL] [Abstract][Full Text] [Related]
32. The ATPase SRCAP is associated with the mitotic apparatus, uncovering novel molecular aspects of Floating-Harbor syndrome.
Messina G; Prozzillo Y; Delle Monache F; Santopietro MV; Atterrato MT; Dimitri P
BMC Biol; 2021 Sep; 19(1):184. PubMed ID: 34474679
[TBL] [Abstract][Full Text] [Related]
33. De Novo Mutation of KAT6B Gene Causing Atypical Say-Barber-Biesecker-Young-Simpson Syndrome or Genitopatellar Syndrome.
Li G; Li N; Li J; Ding Y; Yu T; Wang X; Wang J
Fetal Pediatr Pathol; 2017 Apr; 36(2):130-138. PubMed ID: 28426343
[TBL] [Abstract][Full Text] [Related]
34. Molecular Genetics and Pathogenesis of the Floating Harbor Syndrome: Case Report of Long-Term Growth Hormone Treatment and a Literature Review.
Turkunova ME; Barbitoff YA; Serebryakova EA; Polev DE; Berseneva OS; Bashnina EB; Baranov VS; Glotov OS; Glotov AS
Front Genet; 2022; 13():846101. PubMed ID: 35664296
[No Abstract] [Full Text] [Related]
35. Effects of long-term growth hormone therapy in a girl with Floating-Harbor syndrome.
Son HW; Lee JE; Oh SH; Keum C; Chung WY
Ann Pediatr Endocrinol Metab; 2020 Jun; 25(2):126-131. PubMed ID: 32615693
[TBL] [Abstract][Full Text] [Related]
36. Two mutations in exon XII of the protein S alpha gene in four thrombophilic families resulting in premature stop codons and depressed levels of mutated mRNA.
Andersen BD; Lind B; Philips M; Hansen AB; Ingerslev J; Thorsen S
Thromb Haemost; 1996 Aug; 76(2):143-50. PubMed ID: 8865520
[TBL] [Abstract][Full Text] [Related]
37. Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome.
Gastier JM; Berg MA; Vesterhus P; Reiter EO; Francke U
Hum Mutat; 2000 Oct; 16(4):323-33. PubMed ID: 11013443
[TBL] [Abstract][Full Text] [Related]
38. Two hits in one: whole genome sequencing unveils LIG4 syndrome and urofacial syndrome in a case report of a child with complex phenotype.
Fadda A; Butt F; Tomei S; Deola S; Lo B; Robay A; Al-Shakaki A; Al-Hajri N; Crystal R; Kambouris M; Wang E; Marincola FM; Fakhro KA; Cugno C
BMC Med Genet; 2016 Nov; 17(1):84. PubMed ID: 27855655
[TBL] [Abstract][Full Text] [Related]
39. Novel Findings in Floating-Harbor Syndrome and a Mini-Review of the Literature.
Ercoskun P; Yuce-Kahraman C
Mol Syndromol; 2021 Mar; 12(1):52-56. PubMed ID: 33776628
[TBL] [Abstract][Full Text] [Related]
40. Dissecting the Wolf-Hirschhorn syndrome phenotype: WHSC1 is a neurodevelopmental gene contributing to growth delay, intellectual disability, and to the facial dysmorphism.
Zollino M; Doronzio PN
J Hum Genet; 2018 Aug; 63(8):859-861. PubMed ID: 29884796
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
